Home / Cancer
Cancer
| 3 min read
QDX and Prelude Therapeutics are developing drugs that selectively target the JAK2 V617F mutation, offering hope for patients with myeloproliferative neoplasms.
| 3 min read
Scientists created a novel platform that uses the advantages of both bacteria and viruses to attack tumors.
| 4 min read
A new deep learning model combines dermoscopic images with patient data to improve accuracy and reduce false positives.
| 2 min read
The new investment accelerates development of a potential breakthrough therapy targeting the one-carbon metabolic pathway.
| 4 min read
Rare disease approvals, multi-billion-dollar deals, and more led this week’s headlines.
| 4 min read
Early clinical trials show that a KRAS G12D inhibitor can shrink tumors in patients with advanced pancreatic and other solid cancers.
| 4 min read
Ignota Labs is using artificial intelligence to revive shelved drug candidates, reduce clinical risk, and cut carbon emissions.
| 2 min read
With so many cancer patients not responding to these immunotherapies, researchers are looking for new ways to boost their efficacy.
| 3 min read
The new therapy combines a chemically enhanced drug with tumor-targeted delivery to overcome resistance and reduce side effects.
| 3 min read
The therapy exploits the properties of a neutrophil-derived enzyme to selectively kill tumor cells while preserving healthy immune cells.
| 2 min read
Researchers highlight how intra-tumoral microbiota shape tumor growth, drug resistance, and treatment response.
| 3 min read
Ryvu’s ONCO Prime platform uncovers novel molecular vulnerabilities and actionable targets in colorectal and other cancers.
